Therefore, SCFAs may play an important role in inhibiting the growth of hematologic malignancies by regulating the NF-κB pathway, inhibiting the release of inflammatory factors, and inducing the expression of anti-inflammatory cytokines. Here, NFKB1 is linked to hematologic disorder.